Michael Rabinowitz

Chief Commercial Officer, Oramed Pharmaceuticals.

Companies

Oramed PharmaceuticalsChief Commercial Officer Aug 6, 2021 to Jan 5, 2022¹

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

Oramed Pharmaceuticals ORMP109,468 shares²$457.6K at $4.18Jan 3, 2022

As of each latest filing. The line shows shares held over time.

Recent filings

Jan 3, 2022Granted 19,000 shares of Oramed Pharmaceuticals²
Dec 28, 2021Shares withheld for tax 9,532 shares at $12.98 of Oramed Pharmaceuticals³

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGAROramed Pharmaceuticals, Chief Commercial Officer
2
SEC EDGAROramed Pharmaceuticals shares after the filing of Jan 3, 2022
3
SEC EDGARForm 4 filed Dec 30, 2021